Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEAMERICAN:ASTNYSE:NOG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASTAsterias Biotherapeutics$0.00$0.00$0.51▼$2.05$111KN/A136,653 shs1,000 shsNOGNorthern Oil and Gas$26.53+0.9%$26.23$19.88▼$44.31$2.62B1.471.51 million shs1.48 million shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASTAsterias Biotherapeutics0.00%0.00%0.00%0.00%0.00%NOGNorthern Oil and Gas+0.87%+4.33%+7.06%-24.59%-34.34%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationASTAsterias BiotherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ANOGNorthern Oil and Gas4.1242 of 5 stars4.20.03.30.02.73.31.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASTAsterias Biotherapeutics 0.00N/AN/AN/ANOGNorthern Oil and Gas 2.44Hold$43.5063.97% UpsideCurrent Analyst Ratings BreakdownLatest AST, NOG, ANGS, and UJO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/14/2025NOGNorthern Oil and GasRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSector Perform ➝ Sector Perform$40.00 ➝ $34.004/1/2025NOGNorthern Oil and GasBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$48.00 ➝ $41.003/27/2025NOGNorthern Oil and GasMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$43.00 ➝ $38.002/25/2025NOGNorthern Oil and GasCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$55.00 ➝ $45.002/21/2025NOGNorthern Oil and GasCapital One FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Equal Weight2/13/2025NOGNorthern Oil and GasRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSector Perform ➝ Sector Perform$45.00 ➝ $40.00(Data available from 5/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASTAsterias BiotherapeuticsN/AN/AN/AN/AN/AN/ANOGNorthern Oil and Gas$2.21B1.19$9.54 per share2.78$23.25 per share1.14Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASTAsterias BiotherapeuticsN/AN/A0.00∞N/AN/AN/AN/AN/ANOGNorthern Oil and Gas$922.97M$6.425.164.80N/A23.38%24.41%10.61%7/29/2025 (Estimated)Latest AST, NOG, ANGS, and UJO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/29/2025Q1 2025NOGNorthern Oil and Gas$1.12$1.33+$0.21$1.39$568.87 million$602.10 million2/19/2025Q4 2024NOGNorthern Oil and Gas$1.27$1.11-$0.16$0.71$552.34 million$545.47 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASTAsterias BiotherapeuticsN/AN/AN/AN/AN/ANOGNorthern Oil and Gas$1.806.78%+119.54%28.04%4 YearsLatest AST, NOG, ANGS, and UJO DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/1/2025NOGNorthern Oil and Gasquarterly$0.457.1%6/27/20256/27/20257/31/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASTAsterias BiotherapeuticsN/AN/AN/ANOGNorthern Oil and Gas1.020.921.23Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASTAsterias BiotherapeuticsN/ANOGNorthern Oil and Gas98.80%Insider OwnershipCompanyInsider OwnershipASTAsterias BiotherapeuticsN/ANOGNorthern Oil and Gas2.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableASTAsterias BiotherapeuticsN/A55.66 millionN/ANot OptionableNOGNorthern Oil and Gas3098.70 million97.03 millionOptionableAST, NOG, ANGS, and UJO HeadlinesRecent News About These CompaniesBrevan Howard Capital Management LP Buys Shares of 27,923 Northern Oil and Gas, Inc. (NYSE:NOG)May 10 at 5:38 AM | marketbeat.comAptus Capital Advisors LLC Purchases 42,784 Shares of Northern Oil and Gas, Inc. (NYSE:NOG)May 6, 2025 | marketbeat.comQ2 Earnings Estimate for NOG Issued By Capital One FinancialMay 6, 2025 | marketbeat.comQ2 EPS Estimates for NOG Lowered by Capital One FinancialMay 6, 2025 | americanbankingnews.comNorthern Oil and Gas, Inc. (NYSE:NOG) Shares Sold by Aristotle Capital Boston LLCMay 5, 2025 | marketbeat.comResearch Analysts Issue Forecasts for NOG FY2025 EarningsMay 4, 2025 | marketbeat.comBrokers Set Expectations for NOG FY2025 EarningsMay 4, 2025 | americanbankingnews.comNorthern Oil and Gas (NOG) Reports Q1 Earnings: What Key Metrics Have to SayMay 2, 2025 | zacks.comNorthern Oil and Gas (NYSE:NOG) Shares Gap Up on Earnings BeatMay 2, 2025 | marketbeat.comNorthern's Q1 Earnings Beat Estimates, Revenues Increase Y/YMay 2, 2025 | zacks.comNorthern Oil and Gas, Inc. (NYSE:NOG) Shares Purchased by Aquatic Capital Management LLCMay 2, 2025 | marketbeat.comNorthern Oil and Gas: Strong Q1 2025 Performance, But Share Repurchase Ability May Be ConstrainedMay 2, 2025 | seekingalpha.comNorthern Oil and Gas, Inc. (NYSE:NOG) Q1 2025 Earnings Call TranscriptMay 1, 2025 | insidermonkey.comEmerald Mutual Fund Advisers Trust Sells 157,026 Shares of Northern Oil and Gas, Inc. (NYSE:NOG)May 1, 2025 | marketbeat.comQ1 2025 Northern Oil and Gas Inc Earnings CallMay 1, 2025 | finance.yahoo.comNorthern Oil and Gas in the ‘Catbird Seat’ as Oil Prices PlummetApril 30, 2025 | finance.yahoo.comNorthern oil and gas outlines $850M maintenance CapEx amid strategic flexibility for 2025April 30, 2025 | msn.comNorthern Oil and Gas, Inc. (NOG) Q1 2025 Earnings Call TranscriptApril 30, 2025 | seekingalpha.comNOG Declares $0.45 Quarterly Cash Dividend, 12.5% Increase Year-over-YearApril 30, 2025 | gurufocus.comNOG Declares $0.45 Quarterly Cash Dividend, 12.5% Increase Year-over-YearApril 30, 2025 | businesswire.comSusquehanna Fundamental Investments LLC Acquires Shares of 158,924 Northern Oil and Gas, Inc. (NYSE:NOG)April 30, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy NVIDIA Stock Could Soar Despite Wall Street DowngradesBy Thomas Hughes | April 14, 2025View Why NVIDIA Stock Could Soar Despite Wall Street DowngradesAST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer StockBy Jea Yu | April 21, 2025View AST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer Stock5 Stocks That Crushed Earnings and Guidance ForecastsBy Thomas Hughes | May 8, 2025View 5 Stocks That Crushed Earnings and Guidance ForecastsUPS Stock Forecast: Rebound Underway for United Parcel Service?By Thomas Hughes | May 4, 2025View UPS Stock Forecast: Rebound Underway for United Parcel Service?These 3 Stocks Have Huge Last 12 Months Shareholder YieldsBy Leo Miller | April 18, 2025View These 3 Stocks Have Huge Last 12 Months Shareholder YieldsAST, NOG, ANGS, and UJO Company DescriptionsAsterias Biotherapeutics NYSEAMERICAN:AST$0.0020 0.00 (0.00%) As of 07/10/2019Asterias Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing cell-based therapeutics to treat neurological conditions associated with demyelination, and cellular immunotherapies to treat cancer. Its clinical stage programs include AST-OPC1, an oligodendrocyte progenitor cell population derived from pluripotent stem cells that is in Phase I/IIa clinical trial for spinal cord injuries; AST-VAC2 is a non-patient-specific cancer immunotherapy derived from pluripotent stem cells for the treatment of non-small cell lung cancer; and AST-VAC1, a patient-specific cancer immunotherapy that has completed Phase II clinical trial for the treatment of acute myeloid leukemia. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is headquartered in Fremont, California.Northern Oil and Gas NYSE:NOG$26.53 +0.23 (+0.87%) As of 05/9/2025 03:59 PM EasternNorthern Oil and Gas, Inc., an independent energy company, engages in the acquisition, exploration, exploitation, development, and production of crude oil and natural gas properties in the United States. It primarily holds interests in the Williston Basin, the Appalachian Basin, and the Permian Basin in the United States. The company is based in Minnetonka, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/05 - 05/09 Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs Why Nearly 20 Analysts Raised Meta Price Targets Post-Earnings Strategists Say Hold: Stocks May Beat the 'Sell in May' Trend Here's The Reason Goldman Sachs Is Bullish On MercadoLibre Stock GlobalFoundries Stock Hits Bottom: Is a Rebound Coming? What the ExtraHop Deal Means for CrowdStrike DoorDash’s Uptrend Is Gaining Momentum in 2025 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
